CPHI Americas

Astoriom, a global provider of R&D sample stability and biorepository storage, has expanded the stability storage capabilities at its Tramore site in Ireland to help meet demand for scalable, flexible, regulatory-compliant storage solutions from -60°C to -196°C and ICH (International Council for Harmonisation) temperature-controlled stability conditions. The additional capacity will provide greater storage availability and continuous access to controlled environmental conditions to support R&D and regulatory studies.

Astoriom launched its expanded dedicated cryogenic storage suite in Tramore last year. This investment complements the acquisitions of Nottingham-based MTS Cryo Stores and Cool Repair Scientific UK, and Flagship Biosciences’ North Carolina biorepository operations. 

The Tramore facility complies with industry standards, including ISO 9001 certifications, ensuring adherence to global regulatory requirements. It currently provides stability storage at precise temperature ranges for the safe preservation of samples for biopharmaceutical companies, biotechs, CROs/CDMOs, research institutions, medical device providers, and biobanks. 

Lori A. Ball, CEO, Astoriom, said, “With over 30 years’ experience, Astoriom has established itself as a trusted partner for safeguarding samples globally, operating state-of-the-art facilities in the US, UK, and Ireland. This expansion strengthens our global footprint and continues to serve the evolving needs of our R&D customers who are seeking high-quality, scalable, and regulatory-ready environments.”